1. Home
  2. MLYS vs DOGZ Comparison

MLYS vs DOGZ Comparison

Compare MLYS & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • DOGZ
  • Stock Information
  • Founded
  • MLYS 2019
  • DOGZ 2003
  • Country
  • MLYS United States
  • DOGZ China
  • Employees
  • MLYS N/A
  • DOGZ N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • MLYS Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • MLYS Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • MLYS 510.6M
  • DOGZ 547.0M
  • IPO Year
  • MLYS 2023
  • DOGZ 2017
  • Fundamental
  • Price
  • MLYS $9.56
  • DOGZ $27.83
  • Analyst Decision
  • MLYS Strong Buy
  • DOGZ
  • Analyst Count
  • MLYS 2
  • DOGZ 0
  • Target Price
  • MLYS $27.00
  • DOGZ N/A
  • AVG Volume (30 Days)
  • MLYS 280.6K
  • DOGZ 91.7K
  • Earning Date
  • MLYS 02-12-2025
  • DOGZ 03-04-2025
  • Dividend Yield
  • MLYS N/A
  • DOGZ N/A
  • EPS Growth
  • MLYS N/A
  • DOGZ N/A
  • EPS
  • MLYS N/A
  • DOGZ N/A
  • Revenue
  • MLYS N/A
  • DOGZ $14,847,902.00
  • Revenue This Year
  • MLYS N/A
  • DOGZ N/A
  • Revenue Next Year
  • MLYS N/A
  • DOGZ N/A
  • P/E Ratio
  • MLYS N/A
  • DOGZ N/A
  • Revenue Growth
  • MLYS N/A
  • DOGZ N/A
  • 52 Week Low
  • MLYS $8.58
  • DOGZ $4.98
  • 52 Week High
  • MLYS $16.91
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 42.42
  • DOGZ 40.77
  • Support Level
  • MLYS $8.98
  • DOGZ $27.21
  • Resistance Level
  • MLYS $10.75
  • DOGZ $33.98
  • Average True Range (ATR)
  • MLYS 0.72
  • DOGZ 3.56
  • MACD
  • MLYS 0.02
  • DOGZ -0.13
  • Stochastic Oscillator
  • MLYS 27.49
  • DOGZ 5.95

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: